BRISBANE'S WORLD-FIRST ASTHMA TREATMENT

Written on the 27 July 2015

BRISBANE'S WORLD-FIRST ASTHMA TREATMENT ASTHMA sufferers: Brisbane drug development company Invion (ASX: IVX) has partnered with a global manufacturer to progress development of a novel asthma treatment.

The inhaled INV104 has been coined as a potential new treatment for asthma, which is estimated to afflict 300 million people worldwide.

The global market for asthma therapeutics is more than $22 billion per annum.

The compound already exists but is now being reformulated for inhalation. Hovione Scienta has collaborated with Invion to develop the proprietary novel technology, which is a dry powder formulation of the compound delivered by an inhaler.

Hovione will provide expertise on chemistry, particle engineering, formulation, device and GMP manufacturing, while IVX will oversee all non-clinical and clinical development, and remain responsible for regulatory submissions.

This trajectory for growth comes as IVX has received agreement from the FDA to proceed in accelerated development of the new formulation and device.

IVX CEO and managing director Greg Collier says, both medically and commercially, the new method is superior.

"We are reformulating this compound for inhalation and remain confident that delivering this compound directly into the lung in this manner will provide superior benefit and bypass any problems associated with systemic delivery," says Collier.

"Hovione is the right partner to help us capitalise on this highly promising commercial opportunity."



Latest News

DARK DAYS AHEAD FOR AUSTRALIAN RETAIL AS REPORT FORECASTS MAJOR INDUSTRY ROUT

ALMOST 1,600 retail businesses are at risk of imminent collapse, including 21 major retailers with turnovers of more ...

GOODMAN TAKES PROFIT AND REVENUE DECLINE BUT LOOKS TO CASH IN ON AMAZON'S ARRIVAL

Commercial and industrial property group Goodman (ASX: GMG) has reported underlying full year net profit has dropped ...

REPORTING SEASON WRAP: MONDAY HIGHLIGHTS

* FORTESCUE Metals (ASX: FMG) reported net profit after tax (NPAT) of $2.64 billion for the year to June 30, up fr...

ARIADNE CUTS DEMANDS FOR FOUR ARDENT BOARD SEATS TO TWO AHEAD OF EGM

REBEL shareholders have reduced their demands on embattled theme parks operator Ardent Leisure (ASX: AAD) to give the...

Related News

DARK DAYS AHEAD FOR AUSTRALIAN RETAIL AS REPORT FORECASTS MAJOR INDUSTRY ROUT

ALMOST 1,600 retail businesses are at risk of imminent collapse, including 21 major retailers with turnovers of more ...

REPORTING SEASON WRAP: MONDAY HIGHLIGHTS

* FORTESCUE Metals (ASX: FMG) reported net profit after tax (NPAT) of $2.64 billion for the year to June 30, up fr...

WESFARMERS BOOKS BUMPER PROFIT BUT SUPERMARKET WAR HITS COLES' BOTTOM LINE

SUPERMARKET giant Coles has posted its biggest slide in earnings since it was acquired by Wesfarmers (ASX: WES) 10 ye...

ANALYSTS PREDICT WHAT AUSSIE LIVING IS LIKELY TO BECOME IN THE NEXT CENTURY

AS THE Australian population continues to grow, analysts are predicting what the country is likely to look like wi...

BOOK YOUR FUNCTION SPACE HERE

 

 

 

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter